(2026). Successful Introduction of Lorlatinib After Drug Eruption With Alectinib in ALK‐Positive Lung Adenocarcinoma: A Case Report. Respirology Case Reports.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Successful Introduction of Lorlatinib After Drug Eruption With Alectinib in ALK‐Positive Lung Adenocarcinoma: A Case Report."
Respirology Case Reports 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Successful Introduction of Lorlatinib After Drug Eruption With Alectinib in ALK‐Positive Lung Adenocarcinoma: A Case Report."
Respirology Case Reports, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.